# A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants

> **NCT07532655** · PHASE1 · NOT_YET_RECRUITING · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 44 (estimated)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** SYH2082 Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07532655
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-14
- **Primary completion:** 2026-10-28
- **Final completion:** 2027-02-09
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07532655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07532655, "A Single Ascending Dose Study of SYH2082 Injection in Healthy Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07532655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*